TScan Therapeutics, Inc. (TCRX)
NASDAQ·Healthcare·Biotechnology
$0.32
-2.14%
Mkt Cap $19.57M
Analyst Ratings
Buy
3
Hold
3
Sell
0
Price Target (2 analysts)
$7.50
Range $3.00 – $12.00
Implied Upside
+2240.8%
Consensus $7.50 vs current $0.32
NASDAQ·Healthcare·Biotechnology
$0.32
-2.14%
Mkt Cap $19.57M
Buy
3
Hold
3
Sell
0
Price Target (2 analysts)
$7.50
Range $3.00 – $12.00
+2240.8%
Consensus $7.50 vs current $0.32